GlassScriptPhysician profile
Christal Denton
NPI 1801032594
$929.75
in general payments reported to CMS, 2019-2025
12 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.20 · 2023: $150 · 2024: $443 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $300.72 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $154.96 | 2023-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $114.79 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $111.45 | 2022-2025 | M-M-R II, Vaxneuvance, Rotateq |
| Pfizer INC. | $62.86 | 2023-2024 | |
| Sanofi Pasteur INC. | $39.10 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $37.51 | 2025 | Zoryve |
| Cranial Technologies, INC | $34.73 | 2024 | Doc Band |
| Neos Therapeutics, LP | $28.07 | 2024-2025 | Cotempla Xr-Odt |
| Tris Pharma INC | $18.43 | 2023 | Dyanavel Xr |
| Novo Nordisk INC | $14.05 | 2024 | Wegovy |
| Sobi, INC | $13.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christal Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.